Delirium Treatment Drugs Market Outlook, Trends And Future Opportunities (2024-2031)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Delirium Treatment Drugs Market

Delirium Treatment Drugs Market Outlook, Trends And Future Opportunities (2024-2031)

Delirium Treatment Drugs Market, By Drug Class (Antipsychotics, Anesthetics, Anticonvulsants, Antidepressants, Sedative Hypnotics, Cholinesterase inhibitors), By Diagnosis (Subsyndromal delirium, Delirium tremens, Hypoactive delirium, Hyperactive delirium, Mixed delirium, Others (subtypes)), By End User (Hospitals, Clinics, Homecare, Others (rehab centers, LTC facilities etc.)), By Route of Administration (Oral, Intravenous, Intramuscular, Others (sublingual, transdermal etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Mar 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA58
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Delirium Treatment Drugs Market Expected to Achieve US $ 4.4 Billion by 2031 | CAGR 5.9%

Table Of Contents

  • Chapter 1. Research Methodology and Scope
    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology
  • Chapter 2. Executive Summary
    • Market Landscape
    • Market Size & Forecast
    • Competitive Landscape
  • Chapter 3. Delirium Treatment Drugs Market: Antipsychotics Segment Market Trends, Size, and Future Outlook
    • Antipsychotics Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Antipsychotics Segment Definitions, Technology Landscape
    • Antipsychotics Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Antipsychotics Segment Market Restraints
  • Chapter 4. Delirium Treatment Drugs Market: Anesthetics Segment Market Trends, Size, and Future Outlook
    • Anesthetics Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Anesthetics Segment Definitions, Technology Landscape
    • Anesthetics Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Anesthetics Segment Market Restraints
  • Chapter 5. Delirium Treatment Drugs Market: Anticonvulsants Segment Market Trends, Size, and Future Outlook
    • Anticonvulsants Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Anticonvulsants Segment Definitions, Technology Landscape
    • Anticonvulsants Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Anticonvulsants Segment Market Restraints
  • Chapter 6. Delirium Treatment Drugs Market: Antidepressants Segment Market Trends, Size, and Future Outlook
    • Antidepressants Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Antidepressants Segment Definitions, Technology Landscape
    • Antidepressants Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Antidepressants Segment Market Restraints
  • Chapter 7. Delirium Treatment Drugs Market: Sedative Hypnotics Segment Market Trends, Size, and Future Outlook
    • Sedative Hypnotics Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Sedative Hypnotics Segment Definitions, Technology Landscape
    • Sedative Hypnotics Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Sedative Hypnotics Segment Market Restraints
  • Chapter 8. Delirium Treatment Drugs Market: Cholinesterase Inhibitors Segment Market Trends, Size, and Future Outlook
    • Cholinesterase Inhibitors Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Cholinesterase Inhibitors Segment Definitions, Technology Landscape
    • Cholinesterase Inhibitors Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Cholinesterase Inhibitors Segment Market Restraints
  • Chapter 9. Delirium Treatment Drugs Market: Subsyndromal delirium Segment Market Trends, Size, and Future Outlook
    • Subsyndromal delirium Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Subsyndromal delirium Segment Definitions, Technology Landscape
    • Subsyndromal delirium Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Subsyndromal delirium Segment Market Restraints
  • Chapter 10. Delirium Treatment Drugs Market: Delirium tremens Segment Market Trends, Size, and Future Outlook
    • Delirium tremens Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Delirium tremens Segment Definitions, Technology Landscape
    • Delirium tremens Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Delirium tremens Segment Market Restraints
  • Chapter 11. Delirium Treatment Drugs Market: Hypoactive delirium Segment Market Trends, Size, and Future Outlook
    • Hypoactive delirium Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Hypoactive delirium Segment Definitions, Technology Landscape
    • Hypoactive delirium Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Hypoactive delirium Segment Market Restraints
  • Chapter 12. Delirium Treatment Drugs Market: Hyperactive delirium Segment Market Trends, Size, and Future Outlook
    • Hyperactive delirium Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Hyperactive delirium Segment Definitions, Technology Landscape
    • Hyperactive delirium Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Hyperactive delirium Segment Market Restraints
  • Chapter 13. Delirium Treatment Drugs Market: Mixed delirium Segment Market Trends, Size, and Future Outlook
    • Mixed delirium Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Mixed delirium Segment Definitions, Technology Landscape
    • Mixed delirium Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Mixed delirium Segment Market Restraints
  • Chapter 15. Delirium Treatment Drugs Market: End Users Segment Market Trends, Size, and Future Outlook
    • End Users Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • End Users Segment Definitions, Technology Landscape
    • End Users Segment Market Drivers
      • Product Launches
      • Technology Launches
    • End Users Segment Market Restraints
  • Chapter 15. Delirium Treatment Drugs Market: Routes Segment Market Trends, Size, and Future Outlook
    • Routes Segment Market Size (US$), CAGR (%), and Forecast (2023-2031)
    • Routes Segment Definitions, Technology Landscape
    • Routes Segment Market Drivers
      • Product Launches
      • Technology Launches
    • Routes Segment Market Restraints
  • Chapter 16. Delirium Treatment Drugs Market: Regional Market Trends, Size, and Future Outlook
    • North America
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Europe
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Asia Pacific
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Latin America
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Middle East & Africa
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
  • Chapter 29. Delirium Treatment Drugs Market: Competitive Landscape
    • Pfizer
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Johnson & Johnson
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Eli Lilly
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • AstraZeneca
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Novartis
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Otsuka Pharmaceutical
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • H. Lundbeck
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Teva Pharmaceutical
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Sunovion Pharmaceuticals
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Avadel Pharmaceuticals
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
  • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size is USD 2.8 billion in 2023.

Increasing geriatric population, rising prevalence of target indication, investments in product development.

Safety issues with antipsychotics, misdiagnosis of delirium patients, lack of approved pharmacological interventions.

Antipsychotic drugs are the leading segment with over 40% market share.

Pfizer, Johnson & Johnson, Eli Lilly, AstraZeneca, Novartis etc.

The market is expected to grow at 5.9% CAGR, reaching USD 4.4 billion by 2031.

Increasing geriatric population, rising prevalence of dementia and Alzheimer's disease, growing awareness about delirium management.
Download FREE Sample Buy Now